These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23413900)

  • 1. Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.
    Demaria S; Dustin ML
    Immunotherapy; 2013 Feb; 5(2):109-12. PubMed ID: 23413900
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakthrough of the year 2013. Cancer immunotherapy.
    Couzin-Frankel J
    Science; 2013 Dec; 342(6165):1432-3. PubMed ID: 24357284
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies.
    Jacob JA
    JAMA; 2015 Nov; 314(20):2117-9. PubMed ID: 26599172
    [No Abstract]   [Full Text] [Related]  

  • 4. NKG2D and its ligands.
    Obeidy P; Sharland AF
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocktails for cancer with a measure of immunotherapy.
    Ledford H
    Nature; 2016 Apr; 532(7598):162-4. PubMed ID: 27075078
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
    Ruocco MG; Pilones KA; Kawashima N; Cammer M; Huang J; Babb JS; Liu M; Formenti SC; Dustin ML; Demaria S
    J Clin Invest; 2012 Oct; 122(10):3718-30. PubMed ID: 22945631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D signaling in cancer immunosurveillance.
    López-Soto A; Huergo-Zapico L; Acebes-Huerta A; Villa-Alvarez M; Gonzalez S
    Int J Cancer; 2015 Apr; 136(8):1741-50. PubMed ID: 24615398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Releasing the Brakes on Cancer Immunotherapy.
    Ribas A
    N Engl J Med; 2015 Oct; 373(16):1490-2. PubMed ID: 26348216
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte-associated antigen-4.
    Salama AK; Hodi FS
    Clin Cancer Res; 2011 Jul; 17(14):4622-8. PubMed ID: 21467163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.
    Dias JD; Hemminki O; Diaconu I; Hirvinen M; Bonetti A; Guse K; Escutenaire S; Kanerva A; Pesonen S; Löskog A; Cerullo V; Hemminki A
    Gene Ther; 2012 Oct; 19(10):988-98. PubMed ID: 22071969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of co-inhibitory signals driven by CTLA-4 in immune system].
    Olive D; le Thi S; Xerri L; Hirsch I; Nunès JA
    Med Sci (Paris); 2011 Oct; 27(10):842-9. PubMed ID: 22027421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase.
    Aguilera TA; Giaccia AJ
    Clin Cancer Res; 2017 Jun; 23(12):2928-2933. PubMed ID: 28289089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy using NKG2D and DNAM-1 systems.
    Morisaki T; Onishi H; Katano M
    Anticancer Res; 2012 Jun; 32(6):2241-7. PubMed ID: 22641658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology beats cancer: a blueprint for successful translation.
    Pardoll DM
    Nat Immunol; 2012 Dec; 13(12):1129-32. PubMed ID: 23160205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New checkpoint inhibitors ride the immunotherapy tsunami.
    Mullard A
    Nat Rev Drug Discov; 2013 Jul; 12(7):489-92. PubMed ID: 23812256
    [No Abstract]   [Full Text] [Related]  

  • 16. Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model.
    Sundstedt A; Celander M; Eriksson H; Törngren M; Hedlund G
    J Immunother; 2012 May; 35(4):344-53. PubMed ID: 22495392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 18. MICROBIOME. Microbes aid cancer drugs.
    Leslie M
    Science; 2015 Nov; 350(6261):614-5. PubMed ID: 26542545
    [No Abstract]   [Full Text] [Related]  

  • 19. Checkpoints.
    Allison JP
    Cell; 2015 Sep; 162(6):1202-5. PubMed ID: 26359978
    [No Abstract]   [Full Text] [Related]  

  • 20. Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy.
    Ljunggren HG; Jonsson R; Höglund P
    Scand J Immunol; 2018 Dec; 88(6):e12731. PubMed ID: 30485497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.